当前位置:首页 - 行情中心 - 联环药业(600513) - 财务分析 - 现金流量表

联环药业

(600513)

  

流通市值:41.85亿  总市值:41.85亿
流通股本:2.85亿   总股本:2.85亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,363,871,690.08699,388,521.492,904,021,687.312,037,034,996.33
  收到的税费返还-178,595.169,063,835.2-
  收到其他与经营活动有关的现金26,014,975.529,154,591.7528,603,895.744,110,866.3
  经营活动现金流入小计1,389,886,665.6708,721,708.42,941,689,418.212,081,145,862.63
  购买商品、接受劳务支付的现金937,625,253.3464,967,131.011,826,172,932.891,263,182,059.53
  支付给职工以及为职工支付的现金133,442,845.1477,849,478.75239,244,868.51170,132,783.72
  支付的各项税费73,756,070.740,066,293.86131,755,891.6158,533,205.81
  支付其他与经营活动有关的现金329,679,108.35204,793,306.16758,985,808.82662,178,968.82
  经营活动现金流出小计1,474,503,277.49787,676,209.782,956,159,501.822,254,027,017.88
  经营活动产生的现金流量净额-84,616,611.89-78,954,501.38-14,470,083.61-172,881,155.25
二、投资活动产生的现金流量:
  收回投资收到的现金--5,610,000-
  取得投资收益收到的现金--5,549.58-
  处置固定资产、无形资产和其他长期资产收回的现金净额31,228.52-79,873.9216,468
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计31,228.52-5,695,423.516,468
  购建固定资产、无形资产和其他长期资产支付的现金111,541,941.859,913,763.79271,396,270.6167,767,322.53
  投资支付的现金5,574,166.43-18,060,000125,009,528
  取得子公司及其他营业单位支付的现金--202,240,164.77-
  投资活动现金流出小计117,116,108.2359,913,763.79491,696,435.37292,776,850.53
  投资活动产生的现金流量净额-117,084,879.71-59,913,763.79-486,001,011.87-292,760,382.53
三、筹资活动产生的现金流量:
  取得借款收到的现金768,864,460.47349,109,337.161,539,762,062.841,223,929,218.01
  收到其他与筹资活动有关的现金50,000,00025,000,00055,000,00082,489,000
  筹资活动现金流入小计818,864,460.47374,109,337.161,594,762,062.841,306,418,218.01
  偿还债务支付的现金607,122,500290,037,500887,811,597.85651,569,847.75
  分配股利、利润或偿付利息支付的现金33,015,508.5915,005,619.3152,332,422.2845,126,236.02
  其中:子公司支付给少数股东的股利、利润14,760,991.48-5,365,000-
  支付其他与筹资活动有关的现金33,298,330.9615,000,00062,149,316.2179,828,022.72
  筹资活动现金流出小计673,436,339.55320,043,119.311,002,293,336.34776,524,106.49
  筹资活动产生的现金流量净额145,428,120.9254,066,217.85592,468,726.5529,894,111.52
四、汇率变动对现金及现金等价物的影响-341,247.98-269,396.66-340,194.21160,194.55
五、现金及现金等价物净增加额-56,614,618.66-85,071,443.9891,657,436.8164,412,768.29
  加:期初现金及现金等价物余额278,351,322.05278,351,322.05186,693,885.24186,693,885.24
  期末现金及现金等价物余额221,736,703.39193,279,878.07278,351,322.05251,106,653.53
补充资料:
  净利润14,756,304.71--84,152,794.56-
  资产减值准备300,699.19-10,860,329.06-
  固定资产和投资性房地产折旧46,710,620.9-77,570,122.78-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧--77,570,122.78-
  无形资产摊销11,243,393.1-19,467,387.07-
  长期待摊费用摊销773,682.37-1,501,684.53-
  处置固定资产、无形资产和其他长期资产的损失-15,000-77,537.02-
  固定资产报废损失-16,942.39-993,430.69-
  财务费用19,033,528.13-32,630,390.25-
  投资损失2,683,218.9-8,898,993.87-
  递延所得税998,795.37--18,067,075.56-
  其中:递延所得税资产减少1,482,884.84--6,959,754.97-
    递延所得税负债增加-484,089.47--11,107,320.59-
  存货的减少11,697,668.53--54,175,590.68-
  经营性应收项目的减少-104,134,856.58--24,446,711.81-
  经营性应付项目的增加-91,246,366.07-6,374,325.19-
  现金的期末余额221,736,703.39-278,351,322.05-
  减:现金的期初余额278,351,322.05-186,693,885.24-
  现金及现金等价物的净增加额-56,614,618.66-91,657,436.81-
公告日期2026-08-292026-04-282026-04-212025-10-25
审计意见(境内)标准无保留意见
TOP↑